← Open Payments lookup

ROZALIYA VERNIKOV: Open Payments

NPI 1740362433 · GLEN COVE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,606 in 160 payments from 11 companies in 2025. Trend: 2023 $3,923 · 2024 $4,357 · 2025 $4,606

Food & beverage: $4,606
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.24$762
Axsome Therapeutics, Inc.20$731
Alkermes, Inc.14$571
Teva Pharmaceuticals USA, Inc.25$569
Lundbeck LLC21$431
Otsuka America Pharmaceutical, Inc.12$391
Vanda Pharmaceuticals Inc.14$389
E.R. Squibb & Sons, L.L.C.13$301
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$219
Takeda Pharmaceuticals U.S.A., Inc.11$192

Products named: INGREZZA, Auvelity, REXULTI, AUSTEDO XR, ARISTADA, COBENFY, LYBALVI, CAPLYTA.

Industry payments across NY — which companies pay providers there.